IL-1α and IL-1β have been identified as potent pro-inflammatory cytokines in many neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease or multiple sclerosis [80], and have been suggested to accelerate the progression of neurodegeneration. This evidence concerns the gene IL1A and early-onset autosomal dominant Alzheimer disease.